JP2001064253A - Substance for inducing activity of flutathione-s- transferase and food containing the same - Google Patents

Substance for inducing activity of flutathione-s- transferase and food containing the same

Info

Publication number
JP2001064253A
JP2001064253A JP24082399A JP24082399A JP2001064253A JP 2001064253 A JP2001064253 A JP 2001064253A JP 24082399 A JP24082399 A JP 24082399A JP 24082399 A JP24082399 A JP 24082399A JP 2001064253 A JP2001064253 A JP 2001064253A
Authority
JP
Japan
Prior art keywords
activity
gst
food
substance
isothiocyanate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP24082399A
Other languages
Japanese (ja)
Other versions
JP3899210B2 (en
Inventor
Toshihiko Osawa
俊彦 大澤
Koji Uchida
浩二 内田
Kojiro Morimitsu
康次郎 森光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KINJIRUSHI WASABI KK
Original Assignee
KINJIRUSHI WASABI KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KINJIRUSHI WASABI KK filed Critical KINJIRUSHI WASABI KK
Priority to JP24082399A priority Critical patent/JP3899210B2/en
Publication of JP2001064253A publication Critical patent/JP2001064253A/en
Application granted granted Critical
Publication of JP3899210B2 publication Critical patent/JP3899210B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Seasonings (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain an activity-inducing substance which can activate or increase glutathione-S-transferase(GST) as one of the second phase foreign matter- metabolizing enzymes in biological foreign matter metabolism, and exhibits a strong activity-inducting action, and to obtain a solid, semi-fluidized or fluidized food containing the activity-inducing substance. SOLUTION: This GST activity-inducing substance comprises an ω- methylsulfinylalkylisothiocyanate (the alkyl group has five to eight carbon atoms), especially 6-methylsulfinylhexylisothiocyanate. The food containing the GST activity-inducing substance is obtained by adding the substance to a solid, semi-fluidized or fluidized food, or the like. The food includes health foods.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は生体異物代謝におけ
る第二相異物代謝酵素の一つであるグルタチオン−S−
トランスフエラーゼ(以下、「GST」という。)を活
性化、あるいは増量する活性誘導物質およびこれを含む
食品に係り、特に強力な活性誘導を呈するGSTの活性
誘導物質およびこれを含む食品に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to glutathione-S-
The present invention relates to an activity inducer that activates or increases the amount of transerase (hereinafter, referred to as “GST”) and a food containing the same, and particularly to a GST activity inducer that exhibits strong activity induction and a food containing the same.

【0002】[0002]

【従来の技術】今日、我々の生活している環境には、生
体にとって有害な作用を持つ化学物質等の生体異物が氾
濫している。この中には発癌物質もあり、我々はこのよ
うな発癌物質が日常的に人体内に取り込まれる生活を余
儀なくされている。
2. Description of the Related Art Today, the environment in which we live is flooded with foreign substances such as chemical substances having harmful effects on living organisms. Some of these are carcinogens, and we are forced to live such carcinogens on a daily basis.

【0003】一方、我々の人体には、これら発癌物質を
含む生体異物の代謝のための防御機能として、主に第一
相および第二相の二段階からなる解毒代謝機能が、生体
異物との直接的な接触機会の多い肝臓、胃、腸、肺等の
器官に備わっている。
On the other hand, our human body has a detoxification and metabolism function consisting mainly of two phases, a first phase and a second phase, as a protective function for the metabolism of xenobiotics including these carcinogens. It is found in organs such as the liver, stomach, intestines, and lungs where direct contact is common.

【0004】上述第一相では、酸化反応、還元反応、加
水分解反応等によって生体異物の極性を上げ、水溶性を
高める。さらに、上述第二相では、各種抱合反応等によ
り生体異物(第一相で代謝された異物も含む)の水溶性
を一層高め、無毒化して体外に排出しやすくする。
[0004] In the first phase, the polarity of the xenobiotic is increased by an oxidation reaction, a reduction reaction, a hydrolysis reaction, etc., and the water solubility is increased. Furthermore, in the above-mentioned second phase, the water solubility of the xenobiotics (including the xenobiotic metabolized in the first phase) is further enhanced by various conjugation reactions and the like, so that the xenobiotics are detoxified and easily excreted outside the body.

【0005】GSTは還元型グルタチオンと種々の親電
子化合物を抱合させる酵素、具体的には、生体異物とグ
ルタチオンとの抱合反応を触媒する酵素であって、第二
相異物代謝酵素の一つであり、一群の機能を異にする分
子種からなる多機能酵素である。すなわち、これは解毒
酵素としての機能、例えば、様々な外因性有機化合物を
グルタチオン抱合する機能を保持するほか、胆汁酸、ビ
リルビン、ステロイドホルモン等を結合する結合タンパ
クとしての機能をも保持している。
GST is an enzyme that conjugates reduced glutathione with various electrophilic compounds, specifically, an enzyme that catalyzes the conjugation reaction between a xenobiotic and glutathione, and is one of the second-phase xenobiotic metabolizing enzymes. A multifunctional enzyme consisting of a group of molecular species having different functions. That is, it has a function as a detoxifying enzyme, for example, a function of conjugating various exogenous organic compounds to glutathione, and also has a function as a binding protein that binds bile acids, bilirubin, steroid hormones, and the like. .

【0006】また、生体を構成する脂質、あるいは食餌
として摂取している脂質は体内で自動的に酸化されて過
酸化物となり、この過酸化物がさらに酸化されて4−ハ
イドロキシノネナール等の酸化生成物となる。これらの
脂質過酸化物や酸化生成物、特に酸化生成物はDNAや
生体組織を損傷して動脈硬化やアルツハイマー等の様々
な疾病を誘発したり、生体の老化を促進させたりする原
因物質であることもわかっている。これはいわゆる酸化
ストレスと称されるものである。GSTはこれらの脂質
過酸化物や酸化生成物についても抱合化を触媒し、無毒
化して体外に排出しやすくする。
[0006] Lipids constituting the body or lipids ingested as food are automatically oxidized in the body into peroxides, and the peroxides are further oxidized to produce oxidized products such as 4-hydroxynonenal. Things. These lipid peroxides and oxidation products, particularly oxidation products, are substances that damage DNA and living tissues, induce various diseases such as arteriosclerosis and Alzheimer, and promote aging of living bodies. I know that. This is what is called oxidative stress. GST also catalyzes the conjugation of these lipid peroxides and oxidation products, detoxifies them, and facilitates their excretion outside the body.

【0007】このようなGSTは活性が一層向上された
り、増量されたりすれば、上述の第二相抱合反応が一層
活発化され、この結果、発癌物質等の生体異物の解毒代
謝機能が向上されて発癌の危険性が低減することにな
る。
[0007] If the activity of such GST is further improved or increased, the above-described second phase conjugation reaction is further activated, and as a result, the detoxification and metabolic function of xenobiotics such as carcinogens is improved. Thus, the risk of carcinogenesis is reduced.

【0008】さらに、GSTの活性向上や増量により、
脂質酸化生成物による酸化ストレスを一層低減させるこ
ともでき、この結果、脂質酸化生成物が原因となって生
じる動脈硬化やアルツハイマー等を有効に防止すること
になる。
Further, by improving the activity and increasing the amount of GST,
Oxidative stress due to lipid oxidation products can be further reduced, and as a result, arteriosclerosis, Alzheimer's, etc. caused by lipid oxidation products can be effectively prevented.

【0009】GSTの活性化を向上したり増量させる物
質として、従来、ブロッコリーに含まれるスルホラフア
ン(4−メチルスルフイニルブチルイソチオシアネー
ト)が他のイソチオシアネート類に比して特に強いGS
T活性誘導を呈することが確認されている。さらに、化
学発癌剤によるラットの発癌がスルホラフアンの作用に
よって有効に抑制されることも確認されている。
As a substance for improving or increasing the activation of GST, sulforaphane (4-methylsulfinylbutyl isothiocyanate) conventionally contained in broccoli is particularly strong GS as compared with other isothiocyanates.
It has been confirmed to exhibit T activity induction. Furthermore, it has been confirmed that carcinogenesis in rats by a chemical carcinogen is effectively suppressed by the action of sulforaphane.

【0010】[0010]

【発明が解決しようとする課題】しかし、上述のスルホ
ラフアンは相当に強いGST活性誘導を呈するものの、
未だ不充分であり、有害な化学物質や生体異物が益々氾
濫し、かつ脂質酸化生成物による酸化ストレスも一層の
増大を余儀なくされる昨今では、一層強力なGST活性
誘導物質、あるいはこれを含む食品の開発が強く望まれ
ている。
However, although the above-mentioned sulforaphanes exhibit considerably strong GST activity induction,
In recent years, which are still inadequate, harmful chemicals and xenobiotics are increasingly flooded, and oxidative stress due to lipid oxidation products is further increased, these days, stronger GST activity inducers or foods containing them The development of is strongly desired.

【0011】そこで、本発明の目的は一層強力なGST
活性誘導を呈し、これにより解毒代謝機能が向上されて
発癌抑制作用を呈し、かつ酸化ストレス軽減作用をも呈
し、上述の公知技術に存する欠点を改良したGST活性
誘導物質およびこれを含む固形状、半流動状または流動
状の食品を提供することにある。
Therefore, an object of the present invention is to provide a more powerful GST.
GST activity-inducing substance which exhibits activity induction, thereby exhibiting a carcinogenesis-suppressing action by improving the detoxification metabolic function, and also exhibiting an oxidative stress-reducing action, and a solid form containing the GST activity-inducing substance, which has improved the disadvantages of the above-mentioned known techniques, It is to provide a semi-liquid or liquid food.

【0012】[0012]

【課題を解決するための手段】上述の目的を達成するた
め、本発明のGST活性誘導物質によれば、ω−メチル
スルフイニルアルキルイソチオシアネート(アルキル基
の炭素数5〜8)、好ましくは6−メチルスルフイニル
ヘキシルイソチオシアネートからなることを特徴とす
る。
In order to achieve the above object, according to the GST activity inducer of the present invention, ω-methylsulfinylalkyl isothiocyanate (alkyl group having 5 to 8 carbon atoms), preferably It is characterized by comprising 6-methylsulfinylhexyl isothiocyanate.

【0013】さらに、上述の目的を達成するため、本発
明のGST活性誘導物質を含む固形状、半流動状または
流動状の食品によれば、GST活性誘導物質としてω−
メチルスルフイニルアルキルイソチオシアネート(アル
キル基の炭素数5〜8)、好ましくは6−メチルスルフ
イニルヘキシルイソチオシアネートを含むことを特徴と
する。
Further, in order to achieve the above-mentioned object, according to the solid, semi-liquid or fluid food containing the GST activity-inducing substance of the present invention, the GST activity-inducing substance is ω-.
It is characterized by including methylsulfinylalkylisothiocyanate (alkyl group having 5 to 8 carbon atoms), preferably 6-methylsulfinylhexylisothiocyanate.

【0014】[0014]

【発明の実施の態様】以下、本発明を具体的に詳述す
る。
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail.

【0015】本発明にかかる上述のGST活性誘導物質
であるω−メチルスルフイニルアルキルイソチオシアネ
ートは化学的に合成された物質であってもよく、また、
アブラナ科植物からの抽出物であってもよい。これら物
質として、具体的には5−メチルスルフイニルペンチル
イソチオシアネート、6−メチルスルフイニルヘキシル
イソチオシアネート、7−メチルスルフイニルヘプチル
イソチオシアネートおよび8−メチルスルフイニルオク
チルイソチオシアネートが挙げられるが、この中で、特
に6−メチルスルフイニルヘキシルイソチオシアネート
が好ましい。
The above-mentioned GST activity inducer ω-methylsulfinylalkylisothiocyanate according to the present invention may be a chemically synthesized substance.
It may be an extract from cruciferous plants. Specific examples of these substances include 5-methylsulfinylpentyl isothiocyanate, 6-methylsulfinylhexyl isothiocyanate, 7-methylsulfinylheptyl isothiocyanate and 8-methylsulfinyloctyl isothiocyanate. Of these, 6-methylsulfinylhexylisothiocyanate is particularly preferred.

【0016】上述GST活性誘導物質の合成方法を説明
すると、次のとおりである。
The method for synthesizing the above-mentioned GST activity inducer will be described as follows.

【0017】原理的には Kiaer等の方法に従う。(Kiaer
etal. Acta chem.Scand ・11、1298、1957年)。出発物
質としてω−クロロアルケノールを用い、CH3 −SN
aと還流してω−メチルチオアルケノールを得、これに
SOCl2 を作用させてω−クロロアルケノールメチル
サルフアイドを得る。
In principle, it follows the method of Kiaer et al. (Kiaer
etal. Acta chem. Scand, 11, 1298, 1957). Using ω-chloroalkenol as a starting material, CH 3 -SN
The mixture was refluxed with a to obtain ω-methylthioalkenol, which was then treated with SOCl 2 to obtain ω-chloroalkenol methyl sulfide.

【0018】次に、Gabriel 法を用いてアミノ基を導入
し、N−(ω−メチルチオアルキル)−フタルイミドを
生成し、これにヒドラジン水化物を加えて還流し、ω−
メチルチオアルキルアミンを得る。さらに、Li等の方法
(Lietal.J.Org.Chem., 62,4539、1997年)に従い、チ
ウラムジスルフイドを経て得られたω−メチルチオアル
キルイソチオシアネートをmCPBAでメチルチオ基を
酸化し、ω−メチルスルフイニルアルキルイソチオシア
ネートを得る。
Next, an amino group was introduced using the Gabriel method to produce N- (ω-methylthioalkyl) -phthalimide, to which hydrazine hydrate was added and refluxed to obtain ω-
A methylthioalkylamine is obtained. Further, according to the method of Li et al. (Lietal. J. Org. Chem., 62, 4539, 1997), the methylthio group of ω-methylthioalkylisothiocyanate obtained via thiuram disulfide is oxidized with mCPBA, and ω -To obtain methylsulfinylalkylisothiocyanate.

【0019】アブラナ科植物としては各種の野菜、果物
が挙げられるが、特に沢わさび(Eutrema wasabiもしく
はWasabia japonica) およびクレソンが強いGST活性
誘導を呈するので好ましい。
Examples of the cruciferous plants include various vegetables and fruits, and especially, wasabi (Eutrema wasabi or Wasabia japonica) and watercress are preferable because they exhibit strong GST activity induction.

【0020】ω−メチルスルフイニルアルキルイソチオ
シアネートの沢わさびおよびクレソンからの抽出に当た
っては、沢わさびおよびクレソンを水や有機溶媒で抽出
するか、水蒸気蒸溜や分子蒸溜等の蒸溜法で抽出するこ
とが好ましいが、特にこれらの方法に限定されるもので
はない。
In extracting ω-methylsulfinylalkylisothiocyanate from wasabi and watercress, the wasabi and watercress may be extracted with water or an organic solvent, or by a distillation method such as steam distillation or molecular distillation. Is preferred, but the method is not particularly limited to these methods.

【0021】例えば、沢わさびの有機溶剤での具体的抽
出方法を示すと、沢わさびをすりおろした後、酢酸エチ
ル溶媒で抽出し、この抽出液を無水硫酸ナトリウムで脱
水の後、エバポレータで濃縮し、ω−メチルスルフイニ
ルアルキルイソチオシアネートを得る。(後述の実施例
1を参照。)この方法は特に6−メチルスルフイニルヘ
キシルイソチオシアネートの抽出に最適である。
For example, a specific method for extracting wasabi with an organic solvent is as follows. After the grated horseradish is extracted, it is extracted with an ethyl acetate solvent, and the extract is dehydrated with anhydrous sodium sulfate and concentrated with an evaporator. Then, ω-methylsulfinylalkyl isothiocyanate is obtained. (See Example 1 below.) This method is particularly suitable for the extraction of 6-methylsulfinylhexylisothiocyanate.

【0022】ω−メチルスルフイニルアルキルイソチオ
シアネートのクレソンからの抽出に当たっても沢わさび
と同様に抽出される。例えば、クレソンをすりつぶした
後、酢酸エチル溶媒で抽出し、この抽出液を無水硫酸ナ
トリウムで脱水の後、エバポレータで濃縮し、ω−メチ
ルスルフイニルアルキルイソチオシアネートを得る。こ
の方法は特に、7−メチルスルフイニルヘプチルイソチ
オシアネートや8−メチルスルフイニルオクチルイソチ
オシアネートの抽出に最適である。
When ω-methylsulfinylalkylisothiocyanate is extracted from watercress, it is extracted in the same manner as wasabi. For example, watercress is ground, extracted with an ethyl acetate solvent, and the extract is dehydrated with anhydrous sodium sulfate and concentrated by an evaporator to obtain ω-methylsulfinylalkylisothiocyanate. This method is particularly suitable for extracting 7-methylsulfinylheptyl isothiocyanate and 8-methylsulfinyloctyl isothiocyanate.

【0023】なお、上述抽出液は抽出、濃縮の後、液液
分配法、クロマトグラフイー法、分子蒸溜、精留等、任
意の方法によって精製される。
The above-mentioned extract is extracted and concentrated, and then purified by any method such as a liquid-liquid distribution method, a chromatographic method, molecular distillation, and rectification.

【0024】このようにして得られた本発明にかかるG
ST活性誘導物質であるω−メチルスルフイニルアルキ
ルイソチオシアネートは強力なGST活性誘導作用を有
するものであり、これを医薬品としてあるいは後述のと
おり食品として、人体内や動物体内に投与することによ
り解毒代謝機能が強力に向上されて発癌が抑制され、か
つ酸化ストレスが軽減される。
The thus obtained G according to the present invention
The ST activity inducer ω-methylsulfinylalkyl isothiocyanate has a strong GST activity inducing effect, and is detoxified by administering it to a human or animal body as a pharmaceutical or as a food as described below. Metabolic function is strongly improved, carcinogenesis is suppressed, and oxidative stress is reduced.

【0025】上述のGST活性誘導物質は食品として人
体内や動物体内に投与しても上述と同様、解毒代謝機能
が強力に向上されて発癌が抑制され、酸化ストレスも軽
減される。
When the above-mentioned GST activity-inducing substance is administered to humans or animals as foods, the detoxification metabolic function is strongly improved, carcinogenesis is suppressed, and oxidative stress is reduced, as described above.

【0026】本発明にかかる上述の食品としては、社会
通念上食品として認知されている固形状、半流動状、流
動状等の食品が挙げられる。これら食品の中にはもちろ
ん、社会通念上健康食品として認知されている固形状、
半流動状、流動状等の食品も含まれる。
Examples of the above-mentioned food according to the present invention include solid, semi-fluid, and fluid foods which are generally recognized as foods in the society. Among these foods, of course, the solid state, which is recognized as a health food by social wisdom,
It also includes semi-liquid and fluid foods.

【0027】固形状食品としては、例えば、ビスケット
状、シート状、錠剤、顆粒粉末等の形態の一般食品およ
び健康食品が挙げられる。半流動状食品としては、例え
ば、ペースト状、練り状、ゼリー状、ゲル状等の形態の
一般食品および健康食品が挙げられる。流動状食品とし
ては、例えば、ジュース、茶、清涼飲料、ドリンク剤等
の形態の一般食品および健康食品が挙げられる。なお、
これら健康食品には厚生省許可にかかる特定保健用食
品、具体的には、整腸、コレステロール調節、血圧調
節、高吸収性ミネラル、歯の健康維持(虫歯予防)、血
糖調節、食後の血中中性脂肪抑制等の各機能を有する成
分がそれぞれ配合された食品も含まれる。
Examples of solid foods include general foods and health foods in the form of biscuits, sheets, tablets, granules and the like. Examples of the semi-liquid food include general foods and health foods in the form of paste, paste, jelly, gel and the like. Examples of the fluid food include general foods and health foods in the form of juice, tea, soft drinks, drinks, and the like. In addition,
These health foods include special health foods licensed by the Ministry of Health and Welfare, specifically, intestinal control, cholesterol control, blood pressure control, high absorbable minerals, maintenance of dental health (prevention of dental caries), blood sugar control, postprandial blood levels. Foods in which components having various functions such as suppression of essential fats are also included.

【0028】また、上述のGST活性誘導物質そのもの
からなる単味食品やアブラナ科植物由来の食品であって
もよく、あるいはこれに賦型剤、調味料、香料等を適宜
配合して可食性や嗜好性を向上ささたものであってもよ
い。
Further, it may be a simple food consisting of the above-mentioned GST activity-inducing substance itself or a food derived from cruciferous plants, or may be appropriately mixed with excipients, seasonings, flavors and the like to improve edibility. It may have improved palatability.

【0029】さらに、上述のGST活性誘導物質あるい
はこれを含むアブラナ科植物を、粉わさび、練りわさ
び、練りカラシ等の香辛調味料、畜肉製品、魚肉製品、
缶詰、フリーズドライ食品、レトルトパウチ食品、冷凍
食品等の加工食品や、麺類、惣菜、調味液、マヨネー
ズ、ドレッシング、だし汁、たれ、ソース、パン、和洋
菓子、漬物等、広範囲の食品に任意の割合で添加したも
のであってもよい。
Further, the above-mentioned GST activity-inducing substance or a cruciferous plant containing the same can be prepared by adding spice seasonings such as powdered wasabi, kneaded wasabi and kneaded mustard, animal meat products, fish meat products,
Processed foods such as canned foods, freeze-dried foods, retort pouch foods, frozen foods, noodles, side dishes, seasonings, mayonnaise, dressings, broths, sauces, breads, Japanese and Western sweets, pickles, etc. May be added.

【0030】[0030]

【発明の実施例】以下、本発明を実施例によって説明す
るが、本発明はこれら実施例によって制限されるもので
はない。
The present invention will be described below with reference to examples, but the present invention is not limited to these examples.

【0031】実施例1 沢わさびをすりおろした後、これに2倍重量の酢酸エチ
ル溶媒を加えて一晩放置した。次いで、酢酸エチル層を
分離し、無水硫酸ナトリウムで脱水後、エバポレータで
濃縮して抽出物を得た。
Example 1 After wasabi waster was ground, double weight ethyl acetate solvent was added thereto, and the mixture was allowed to stand overnight. Next, the ethyl acetate layer was separated, dehydrated with anhydrous sodium sulfate, and concentrated with an evaporator to obtain an extract.

【0032】次に得られた沢さわび抽出物について次の
ようにして成分の分離、同定を行った。
Next, the components of the obtained wasabi extract were separated and identified as follows.

【0033】まず、沢さわび抽出物をシリカゲルカラム
クロマトグラフィーに供し、ヘキサン/酢酸エチル混合
溶媒(酢酸エチル含量を0、25、50、75、100
%と段階的に上昇)、アセトンで順次溶出した。得られ
たアセトン溶出画分をエバポレータで濃縮して分画物を
得た。この分画物をさらに高速液体クロマトグラフイー
(カラム:Develosil ODS-HG-5、溶出溶媒;メタノール
/水=40/60、流速;2.0ml/分)を用いて精製
し、6−メチルスルフイニルヘキシルイソチオシアネー
トを得た。得られた6−メチルスルフイニルヘキシルイ
ソチオシアネートはNMR、IR、MSの機器分析の結
果からそのものであることが確認された。
First, the Sawasabi washi extract was subjected to silica gel column chromatography, and a mixed solvent of hexane / ethyl acetate (ethyl acetate content: 0, 25, 50, 75, 100
%), And eluted with acetone. The obtained acetone-eluted fraction was concentrated by an evaporator to obtain a fraction. This fraction was further purified using high performance liquid chromatography (column: Develosil ODS-HG-5, elution solvent: methanol / water = 40/60, flow rate: 2.0 ml / min), and 6-methylsulfur Finylhexyl isothiocyanate was obtained. The obtained 6-methylsulfinylhexyl isothiocyanate was confirmed to be the same as the result of the instrumental analysis by NMR, IR and MS.

【0034】次いで、6−メチルスルフイニルヘキシル
イソチオシアネートをマウスに投与してGST活性誘導
作用を測定した。投与方法およびGST活性度の測定は
以下に示した方法にて行った。
Next, 6-methylsulfinylhexylisothiocyanate was administered to mice, and the GST activity-inducing action was measured. The administration method and the measurement of GST activity were performed by the methods described below.

【0035】投与実験 実験動物には4週齢のICRマウス(雌)(日本Slc 社
製) を用い、4週間普通食(20%カゼイン食)を自由
摂取させた。その後、経口ゾンデ(NIS式フレキシブ
ルゾンデ、夏目製作所製)を用いて、ゴマ油100μl
中に15μモル/マウス/日となるように6−メチルス
ルフイニルヘキシルイソチオシアネートおよび4−メチ
ルスルフイニルブチルイソチオシアネート(スルホラフ
アン)をそれぞれ別々に溶解、調製した。これらを別々
の群のマウスにそれぞれ毎朝10時に胃内強制投与を5
日間連続して行った。対照としてゴマ油のみを投与した
群と、何も投与しなかった群を作成した。なお、各群に
は5匹のマウスを使用した。
Administration Experiment The experimental animals were 4-week-old ICR mice (females) (manufactured by Slc Japan) and were fed a normal diet (20% casein diet) for 4 weeks. Then, using an oral sonde (NIS flexible sonde, manufactured by Natsume Seisakusho), 100 μl of sesame oil
6-Methylsulfinylhexylisothiocyanate and 4-methylsulfinylbutylisothiocyanate (sulforaphane) were separately dissolved and prepared at a concentration of 15 μmol / mouse / day. These were administered to different groups of mice by intragastric gavage at 10 am each morning.
Went on for consecutive days. As a control, a group to which only sesame oil was administered and a group to which nothing was administered were prepared. In addition, 5 mice were used for each group.

【0036】5日目の投与終了後、24時間後に採血し
て屠殺し、肝臓を切除し液体窒素下で急速冷凍して−8
0℃で保存した。その後、得られた肝臓は4倍重量のT
ED緩衝液を加え、氷冷しながらホモジネートした。ホ
モジネート液は予備遠心分離した後、上清をさらに10
0,000Gで1時間超遠心分離した。GST活性測定に
は得られた各上清を100倍に希釈したものを試料とし
て用い、以下の測定法にて測定した。
At the end of the administration on the 5th day, 24 hours later, blood was collected and sacrificed. The liver was excised and rapidly frozen under liquid nitrogen for -8 days.
Stored at 0 ° C. After that, the obtained liver was 4 times the weight of T
An ED buffer was added and homogenized while cooling on ice. After pre-centrifugation of the homogenate solution, the supernatant
Ultracentrifuged at 000 G for 1 hour. GST activity was measured by the following measurement method using a 100-fold dilution of each of the obtained supernatants as a sample.

【0037】GST活性度測定 原理的にはW.H.Habig (J.Biol.Chem.249、713 、1974
年) 等の方法に従った。すなわち、0.2Mリン酸緩衝液
(pH6.5)0.5ml、10mM還元型グルタチオン水
溶液0.1ml、精製水0.2mlの混合液に、上述で得ら
れた試料を0.1ml加え、攪拌の後、10mM CDN
B(1−クロロ−2,4−ジニトロベンゼン)100μ
lを添加し、反応を開始させ、次いで、340nmの吸
光度を3分間15秒毎に樹定し、検量線より活性を測定
した。
GST activity is measured in principle by WHHabig (J. Biol. Chem. 249, 713, 1974).
Year). That is, 0.1 ml of the sample obtained above was added to a mixture of 0.5 ml of a 0.2 M phosphate buffer (pH 6.5), 0.1 ml of an aqueous 10 mM reduced glutathione solution, and 0.2 ml of purified water, followed by stirring. Followed by 10 mM CDN
B (1-chloro-2,4-dinitrobenzene) 100 μ
1 was added to start the reaction. Then, the absorbance at 340 nm was established every 15 seconds for 3 minutes, and the activity was measured from the calibration curve.

【0038】タンパク質量の測定 上清のタンパク質量の測定はBCA プロテイン アッ
セイリエージエントキット(PIERCE社型)を使用し、上
清10μlに測定用混合試薬200μlを加え、30分
間インキュベートし、562nmの吸光度を測定してタ
ンパク量を定量することにより行った。
[0038] Measurement of protein content of the protein mass measurement the supernatant using a BCA Protein Assay Li Age entry kit (PIERCE Co. type), the measurement mixed reagent 200μl added to the supernatant 10 [mu] l, incubated for 30 minutes, absorbance at 562nm Was measured to determine the amount of protein.

【0039】GST活性値は以下の算術式で求めた。 GST活性値(ユニット/mg プロテイン)=(34
0nmでの吸光度/3×10×100)/(9.6×タン
パク質量)
The GST activity value was determined by the following arithmetic expression. GST activity value (unit / mg protein) = (34
Absorbance at 0 nm / 3 × 10 × 100) / (9.6 × protein amount)

【0040】測定結果を図1に示す。図1から、本発明
にかかる6−メチルスルフイニルヘキシルイソチオシア
ネート投与にかかるマウスのGST活性が従来のスルホ
ラフアン投与のものよりも相当に高いことがわかる。
FIG. 1 shows the measurement results. From FIG. 1, it can be seen that the GST activity of the mouse administered with 6-methylsulfinylhexylisothiocyanate according to the present invention is considerably higher than that of the mouse administered with conventional sulfolphane.

【0041】[0041]

【発明の効果】以上のとおり、本発明にかかるω−メチ
ルスルフイニルアルキルイソチオシアネート、特に6−
メチルスルフイニルヘキシルイソチオシアネート、ある
いはアブラナ科植物、特に沢わさびやクレソンの抽出物
(抽出エキス)は高いGST活性誘導を呈し、これらを
医薬品として、あるいは食品として生体内に投与するこ
とにより解毒機能が向上されて発癌抑制作用を呈し、か
つ酸化ストレス軽減作用をも呈し、実用上有用な発明で
ある。
As described above, the ω-methylsulfinylalkylisothiocyanate of the present invention, in particular,
Methylsulfinylhexyl isothiocyanate, or an extract of cruciferous plants, especially saw Wasabi or watercress (extracted extract), exhibits high GST activity induction, and detoxification function by administering these as a pharmaceutical or food in vivo. Thus, the present invention exhibits a carcinogenesis-suppressing action and also has an oxidative stress-reducing action, and is a practically useful invention.

【図面の簡単な説明】[Brief description of the drawings]

【図1】マウス投与実験におけるGST活性度を表した
グラフである。
FIG. 1 is a graph showing GST activity in a mouse administration experiment.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 森光 康次郎 愛知県名古屋市天白区植田山1の805(B −201) Fターム(参考) 4B047 LB03 LB08 LG48 LG49 LP01 4C088 AB15 AC11 BA08 BA09 CA01 CA03 CA05 CA11 CA14 MA16 MA27 MA28 MA34 MA35 MA41 MA52 NA05 NA14 ZA18 ZB26 ZC19 ZC21 ZC37 4H006 AA01 AA03 AB10 AB21 AB23 AB28  ────────────────────────────────────────────────── ─── Continued on the front page (72) Inventor Yasujiro Morimitsu 805 (B-201) F-term (Reference) 4B047 LB03 LB08 LG48 LG49 LP01 4C088 AB15 AC11 BA08 BA09 CA01 CA03 CA05 CA11 CA14 MA16 MA27 MA28 MA34 MA35 MA41 MA52 NA05 NA14 ZA18 ZB26 ZC19 ZC21 ZC37 4H006 AA01 AA03 AB10 AB21 AB23 AB28

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 ω−メチルスルフイニルアルキルイソチ
オシアネートからなるグルタチオン−S−トランスフエ
ラーゼの活性誘導物質。ただし、アルキル基の炭素数は
5〜8である。
1. A glutathione-S-transferase activity-inducing substance comprising ω-methylsulfinylalkyl isothiocyanate. However, the alkyl group has 5 to 8 carbon atoms.
【請求項2】 請求項1のω−メチルスルフイニルアル
キルイソチオシアネートが6−メチルスルフイニルヘキ
シルイソチオシアネートである請求項1に記載のグルタ
チオン−S−トランスフエラーゼの活性誘導物質。
2. The glutathione-S-transferase activity inducer according to claim 1, wherein the ω-methylsulfinylalkyl isothiocyanate of claim 1 is 6-methylsulfinylhexylisothiocyanate.
【請求項3】 請求項1のω−メチルスルフイニルアル
キルイソチオシアネートがアブラナ科植物からの抽出物
である請求項1に記載のグルタチオン−S−トランスフ
エラーゼの活性誘導物質。
3. The glutathione-S-transferase activity inducer according to claim 1, wherein the ω-methylsulfinylalkylisothiocyanate of claim 1 is an extract from a cruciferous plant.
【請求項4】 請求項3のアブラナ科植物が沢わさびま
たはクレソンである請求項3に記載のグルタチオン−S
−トランスフエラーゼの活性誘導物質。
4. The glutathione-S according to claim 3, wherein the cruciferous plant of claim 3 is a wasabi or watercress.
-An inducer of the activity of transfelase.
【請求項5】 ω−メチルスルフイニルアルキルイソチ
オシアネートからなるグルタチオン−S−トランスフエ
ラーゼの活性誘導物質を含むことを特徴とする固形状、
半流動状または流動状の食品。ただし、アルキル基の炭
素数は5〜8である。
5. A solid, comprising a glutathione-S-transferase activity inducer comprising ω-methylsulfinylalkylisothiocyanate.
Semi-liquid or liquid food. However, the alkyl group has 5 to 8 carbon atoms.
【請求項6】 請求項5のω−メチルスルフイニルアル
キルイソチオシアネートが6−メチルスルフイニルヘキ
シルイソチオシアネートである請求項5に記載の食品。
6. The food according to claim 5, wherein the ω-methylsulfinylalkyl isothiocyanate of claim 5 is 6-methylsulfinylhexyl isothiocyanate.
【請求項7】 請求項5のω−メチルスルフイニルアル
キルイソチオシアネートがアブラナ科植物、またはこの
抽出物である請求項5に記載の食品。
7. The food according to claim 5, wherein the ω-methylsulfinylalkyl isothiocyanate according to claim 5 is a cruciferous plant or an extract thereof.
【請求項8】 請求項7のアブラナ科植物が沢わさびま
たはクレソンである請求項7に記載の食品。
8. The food according to claim 7, wherein the cruciferous plant according to claim 7 is a wasabi or watercress.
JP24082399A 1999-08-27 1999-08-27 Glutathione-S-transferase complex inducer and food containing the same Expired - Lifetime JP3899210B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP24082399A JP3899210B2 (en) 1999-08-27 1999-08-27 Glutathione-S-transferase complex inducer and food containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24082399A JP3899210B2 (en) 1999-08-27 1999-08-27 Glutathione-S-transferase complex inducer and food containing the same

Publications (2)

Publication Number Publication Date
JP2001064253A true JP2001064253A (en) 2001-03-13
JP3899210B2 JP3899210B2 (en) 2007-03-28

Family

ID=17065238

Family Applications (1)

Application Number Title Priority Date Filing Date
JP24082399A Expired - Lifetime JP3899210B2 (en) 1999-08-27 1999-08-27 Glutathione-S-transferase complex inducer and food containing the same

Country Status (1)

Country Link
JP (1) JP3899210B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001072599A (en) * 1999-09-03 2001-03-21 Kagome Co Ltd Novel hepatic disturbance inhibitor
JP2009515987A (en) * 2005-11-15 2009-04-16 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー Plant-based formulation to improve liver health
WO2010086972A1 (en) * 2009-01-28 2010-08-05 Sekiyama Atsuo Antistress agent
JP2010184892A (en) * 2009-02-12 2010-08-26 Kinjirushi Kk Medicine, quasi-drug, cosmetic, food and beverage and animal feed presenting male hormone-like action
EP2698153A1 (en) * 2001-12-18 2014-02-19 Brassica Foundation for Chemoprotection Research, Inc. Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase II detoxification enzymes
JP2019064956A (en) * 2017-09-29 2019-04-25 金印株式会社 Dopamine production promoter
JP2019064955A (en) * 2017-09-29 2019-04-25 金印株式会社 AMYLOID β TOLERANCE ENHANCER
JP2019064957A (en) * 2017-09-29 2019-04-25 金印株式会社 Neuron elongation promoter
US11065288B2 (en) 2017-09-29 2021-07-20 Kinjirushi Co., Ltd. Neuron activator

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001072599A (en) * 1999-09-03 2001-03-21 Kagome Co Ltd Novel hepatic disturbance inhibitor
EP2698153A1 (en) * 2001-12-18 2014-02-19 Brassica Foundation for Chemoprotection Research, Inc. Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase II detoxification enzymes
JP2009515987A (en) * 2005-11-15 2009-04-16 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー Plant-based formulation to improve liver health
KR101350053B1 (en) * 2005-11-15 2014-01-29 액세스 비지니스 그룹 인터내셔날 엘엘씨 Plant-based formulations for improving liver health
WO2010086972A1 (en) * 2009-01-28 2010-08-05 Sekiyama Atsuo Antistress agent
JP2010184892A (en) * 2009-02-12 2010-08-26 Kinjirushi Kk Medicine, quasi-drug, cosmetic, food and beverage and animal feed presenting male hormone-like action
JP2019064956A (en) * 2017-09-29 2019-04-25 金印株式会社 Dopamine production promoter
JP2019064955A (en) * 2017-09-29 2019-04-25 金印株式会社 AMYLOID β TOLERANCE ENHANCER
JP2019064957A (en) * 2017-09-29 2019-04-25 金印株式会社 Neuron elongation promoter
US11065288B2 (en) 2017-09-29 2021-07-20 Kinjirushi Co., Ltd. Neuron activator
US11839637B2 (en) 2017-09-29 2023-12-12 Kinjirushi Co., Ltd. Neuron activator

Also Published As

Publication number Publication date
JP3899210B2 (en) 2007-03-28

Similar Documents

Publication Publication Date Title
Stark et al. The effect of an ethanol extract derived from fenugreek (Trigonella foenum-graecum) on bile acid absorption and cholesterol levels in rats
Draper et al. The metabolism of malondialdehyde
US8217084B2 (en) Medicinal products incorporating bound organosulfur groups
JP6310690B2 (en) Pet food
JP6759199B2 (en) Blood pressure lowering agent
WO2009136611A1 (en) Glutathione production enhancer, prophylactic/therapeutic agent for diseases associated with lack of glutathione, and food, beverage and feed
JP2001064253A (en) Substance for inducing activity of flutathione-s- transferase and food containing the same
WO2001021182A1 (en) Physical strength enhancing agents and glycogen accumulation promoting agents
WO2008047663A1 (en) Activity enhancer for detoxifying enzyme
JPH10265397A (en) Agent for preventing obesity
JP2011168540A (en) Anti-obesity action promoter, and adiponectin secretion promoter or inhibitor of reduction in the secretion of adiponectin
Kayashita et al. Muscle hypertrophy in rats fed on a buckwheat protein extract
JPWO2019031442A1 (en) Blood flow improver
JP2002153238A (en) Food, feed and pharmaceutical composition
WO2008015950A1 (en) Acat inhibitor
JP6873904B2 (en) Xanthine oxidase inhibitor
US20120122984A1 (en) Methods of Treating Lipomas and Liposarcomas
JP2003286180A (en) Obesity inhibitor and food containing the same
JP3509370B2 (en) Food, feed and pharmaceutical compositions
Zhang et al. Seal meat enzymatic hydrolysates and its digests: A comparison on protein and minerals profiles
JPH09194390A (en) Suppressor for accumulation of fat to internal organ
JP4233796B2 (en) Indigoid-containing glucuronosyltransferase inducer
EP0901755B1 (en) Adsorption of Cholesterol Oxide in Food
JP5917499B2 (en) Panaxadiol-containing composition
JP2011121919A (en) Lipid absorption inhibitor

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050920

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060404

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060502

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060502

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20060721

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060829

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061030

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20061205

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20061225

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 3899210

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100105

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110105

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120105

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120105

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130105

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130105

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term